Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #51225
advertisement
Zhou B
16
Showing records 1 to 16 |
Display all abstracts from
Zhou B
120010
Adjunctive use of netarsudil 0.02% in the treatment of refractory glaucoma: a one year analysis
Zhou B
International Ophthalmology
2024; 44: 335
122340
TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway
Wang X
American Journal of Pathology
2024; 194: 1764-1779
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Klugah-Brown B
Journal of Affective Disorders
2024; 358: 487-499
122340
TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway
Chen K
American Journal of Pathology
2024; 194: 1764-1779
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Bore MC
Journal of Affective Disorders
2024; 358: 487-499
120010
Adjunctive use of netarsudil 0.02% in the treatment of refractory glaucoma: a one year analysis
Yan J
International Ophthalmology
2024; 44: 335
122340
TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway
Yao Y
American Journal of Pathology
2024; 194: 1764-1779
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Liu X
Journal of Affective Disorders
2024; 358: 487-499
120010
Adjunctive use of netarsudil 0.02% in the treatment of refractory glaucoma: a one year analysis
Bekerman VP; Bekerman VP; Khouri AS
International Ophthalmology
2024; 44: 335
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Gan X
Journal of Affective Disorders
2024; 358: 487-499
122340
TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway
Lin Y; Yang J
American Journal of Pathology
2024; 194: 1764-1779
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Biswal BB; Kendrick KM
Journal of Affective Disorders
2024; 358: 487-499
122340
TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway
Zhu Y
American Journal of Pathology
2024; 194: 1764-1779
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Chang DHF
Journal of Affective Disorders
2024; 358: 487-499
122340
TGFβ1-Induced Fibrotic Responses of Conjunctival Fibroblasts through the Wnt/β-Catenin/CRYAB Signaling Pathway
Zhou B
American Journal of Pathology
2024; 194: 1764-1779
119565
The neurostructural consequences of glaucoma and their overlap with disorders exhibiting emotional dysregulations: A voxel-based meta-analysis and tripartite system model
Chang DHF; Zhou B; Becker B
Journal of Affective Disorders
2024; 358: 487-499
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept